SPCC162.01c Antibody

What is SPCC162.01c and why is it significant in research?

SPCC162.01c is a protein coding gene found in Schizosaccharomyces pombe (fission yeast). The significance of this protein in research stems from S. pombe's role as a model organism for studying basic cellular processes that are conserved in humans. Antibodies against SPCC162.01c allow researchers to investigate protein localization, expression levels, and interactions within cellular pathways . Similar to how antibodies like SC27 help researchers understand viral proteins in COVID-19 , SPCC162.01c antibodies serve as tools for understanding fundamental cellular mechanisms in eukaryotic cells.

What sample types are compatible with SPCC162.01c antibody?

SPCC162.01c antibodies are primarily used with S. pombe cell lysates, fixed cells for immunofluorescence, and purified recombinant proteins. While specific validation data for this particular antibody is limited in the provided search results, standard compatibility would include:

These recommendations follow standard protocols similar to those used for other research antibodies like the CD162 antibody described in search result .

How should SPCC162.01c antibody be stored to maintain activity?

For optimal performance, SPCC162.01c antibody should be stored according to standard antibody storage protocols. While specific information for this antibody is not provided in the search results, best practices dictate:

• Long-term storage: -20°C in small aliquots to prevent freeze-thaw cycles

• Working solution: 4°C for up to 2 weeks

• Addition of preservatives (e.g., sodium azide at 0.02%) for longer storage at 4°C

• Avoidance of repeated freeze-thaw cycles, which can lead to denaturation and reduced activity

This approach parallels storage recommendations for similar research antibodies like those used in HIV and COVID-19 research .

What controls should be included when using SPCC162.01c antibody in immunoassays?

When designing experiments with SPCC162.01c antibody, the following controls are essential for result validation:

• Positive control: Lysate from wild-type S. pombe with known SPCC162.01c expression

• Negative control: Lysate from SPCC162.01c knockout strain (if available)

• Isotype control: Non-specific antibody of the same isotype to assess background binding

• Secondary antibody-only control: To evaluate non-specific binding of the secondary antibody

• Blocking peptide control: Pre-incubation of antibody with SPCC162.01c peptide to confirm specificity

This approach is similar to validation strategies used for other research antibodies, such as the N6 antibody described for HIV research , where specificity is confirmed through multiple control conditions.

How should experiments be optimized to reduce background when using SPCC162.01c antibody?

To optimize signal-to-noise ratio in experiments using SPCC162.01c antibody:

• Blocking optimization: Test different blocking solutions (BSA, casein, non-fat milk) at various concentrations (3-5%)

• Antibody titration: Systematically test dilutions to find optimal concentration that provides specific signal with minimal background

• Washing protocol optimization: Increase washing duration or frequency using buffers with appropriate detergent concentration

• Sample preparation improvements: Ensure complete lysis and proper clearing of debris before immunoprecipitation or western blotting

• Pre-absorption: Consider pre-absorbing the antibody with non-specific proteins to reduce cross-reactivity

This methodological approach parallels techniques used in optimizing experiments with other research antibodies, such as the CD162 monoclonal antibody described in search result .

How can SPCC162.01c antibody be utilized in protein interaction studies?

SPCC162.01c antibody can be employed in multiple protein interaction study techniques:

• Co-immunoprecipitation (Co-IP): Use antibody to pull down SPCC162.01c and identify interacting partners by mass spectrometry

• Proximity ligation assay (PLA): Detect in situ protein-protein interactions between SPCC162.01c and suspected binding partners

• Chromatin immunoprecipitation (ChIP): If SPCC162.01c has DNA-binding properties, ChIP can identify genomic binding sites

• Förster resonance energy transfer (FRET): Combine with fluorescently labeled potential interaction partners to measure proximity

• Yeast two-hybrid validation: Confirm Y2H hits using antibody-based methods such as Co-IP

These applications follow similar principles to those employed with other research antibodies, such as the HIV CD4-binding site antibody N6, where binding interactions were thoroughly characterized .

What are the challenges in using SPCC162.01c antibody for quantitative analyses?

Researchers face several challenges when using SPCC162.01c antibody for quantitative studies:

• Epitope accessibility: Protein conformation changes may affect epitope exposure in different experimental conditions

• Post-translational modifications: PTMs may alter antibody recognition, affecting quantitation across different cellular states

• Linear dynamic range: Determining the appropriate detection range for accurate quantification

• Standardization: Developing suitable calibration curves using recombinant SPCC162.01c protein

• Reproducibility across lots: Ensuring consistent performance between different manufacturing lots

These challenges parallel those faced when using other research antibodies, such as the broadly neutralizing antibodies described in HIV research , where binding affinity measurements required careful consideration of these factors.

How can phosphorylation states of SPCC162.01c be investigated using available antibodies?

Investigating phosphorylation states of SPCC162.01c requires specialized approaches:

• Phospho-specific antibodies: While not explicitly mentioned in the search results, researchers may need to develop phospho-specific antibodies against predicted phosphorylation sites in SPCC162.01c

• Combined approaches: Use general SPCC162.01c antibody for immunoprecipitation followed by:

  • Phospho-specific western blotting

  • Mass spectrometry to identify phosphorylation sites

  • Lambda phosphatase treatment as a control to confirm phosphorylation

• Conditional testing: Compare phosphorylation status under different cellular conditions (stress, cell cycle phases, etc.)

This methodological approach is comparable to techniques used to study post-translational modifications in other research contexts, as would be applied in HIV envelope protein studies .

What are common sources of false positives/negatives when using SPCC162.01c antibody and how can they be addressed?

This troubleshooting guide follows standard principles similar to those that would be applied when working with antibodies like SC27 or N6 .

How can contradictory results between different detection methods using SPCC162.01c antibody be reconciled?

When facing contradictory results across different detection methods:

• Consider epitope accessibility: Different methods (WB, IP, IF) expose epitopes differently due to protein folding or denaturation

• Evaluate method sensitivity thresholds: Compare detection limits of each method being used

• Assess buffer compatibility: Some buffers may interfere with antibody binding in certain assays

• Validate with orthogonal approaches: Use alternative methods like RNA expression, tagged proteins, or mass spectrometry

• Test multiple antibody lots or sources: If available, compare results with antibodies targeting different epitopes of SPCC162.01c

This analytical approach mirrors strategies used to resolve discrepancies in antibody-based research for other proteins, as described in the detailed studies of HIV-specific antibodies .

How can SPCC162.01c antibody be adapted for super-resolution microscopy applications?

To effectively use SPCC162.01c antibody in super-resolution microscopy:

• Direct fluorophore conjugation: Directly label the antibody with appropriate fluorophores (Alexa 647, Atto 488, etc.) suitable for STORM, PALM, or STED microscopy

• Antibody fragment generation: Create Fab fragments to reduce the distance between fluorophore and target, improving spatial resolution

• Optimized fixation protocols: Test different fixation methods to maximize epitope accessibility while preserving cellular structure

• Two-step labeling approaches: Use primary SPCC162.01c antibody with specially designed secondary antibodies optimized for super-resolution techniques

• Validation controls: Include robust controls to distinguish specific signal from background at nanoscale resolution

These protocols follow principles similar to advanced imaging techniques that would be applicable to visualizing protein distribution, comparable to approaches used in studying viral proteins .

What strategies can improve SPCC162.01c antibody specificity for challenging applications?

For applications requiring exceptional specificity:

• Affinity purification: Pass crude antibody preparations through antigen columns to isolate only high-affinity antibodies

• Competitive elution: Use graduated concentrations of antigens to separate antibodies by affinity strength

• Cross-adsorption: Pre-incubate with lysates from knockout cells or closely related proteins to remove cross-reactive antibodies

• Isotype-specific secondary antibodies: Use highly specific secondary antibodies to reduce background

• Tandem epitope targeting: Combine with antibodies against other epitopes of SPCC162.01c for verification

This approach follows similar specificity enhancement techniques used in the development of highly specific antibodies like N6, which achieved extraordinary breadth and specificity in HIV neutralization .